Sk Biopharmaceuticals Co Ltd (326030) — Net Asset Quality Index
Sk Biopharmaceuticals Co Ltd (326030) has a Net Asset Quality Index of 70.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩1.32 Trillion minus total liabilities of ₩388.37 Billion yields net assets of ₩932.05 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Sk Biopharmaceuticals Co Ltd (326030) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sk Biopharmaceuticals Co Ltd Net Asset Quality Index Over Time (2016–2025)
This chart shows how Sk Biopharmaceuticals Co Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 70.6%, representing net assets of ₩932.05 Billion against total assets of ₩1.32 Trillion KRW. For live market cap and overall valuation, see 326030 stock market capitalisation.
Annual Net Asset Quality Index for Sk Biopharmaceuticals Co Ltd (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Sk Biopharmaceuticals Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Sk Biopharmaceuticals Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 69.0% | ₩826.27 Billion | ₩1.20 Trillion | ₩372.04 Billion | ▲ +13.6 pp |
| 2024 | 55.4% | ₩573.98 Billion | ₩1.04 Trillion | ₩462.83 Billion | ▲ +11.0 pp |
| 2023 | 44.4% | ₩320.95 Billion | ₩723.17 Billion | ₩402.22 Billion | ▼ -3.3 pp |
| 2022 | 47.7% | ₩316.56 Billion | ₩664.24 Billion | ₩347.68 Billion | ▼ -21.4 pp |
| 2021 | 69.0% | ₩444.19 Billion | ₩643.65 Billion | ₩199.46 Billion | ▼ -6.8 pp |
| 2020 | 75.8% | ₩379.07 Billion | ₩500.24 Billion | ₩121.17 Billion | ▲ +85.1 pp |
| 2019 | -9.4% | ₩-13.03 Billion | ₩139.07 Billion | ₩152.10 Billion | ▼ -70.7 pp |
| 2018 | 61.4% | ₩58.63 Billion | ₩95.54 Billion | ₩36.91 Billion | ▲ +13.3 pp |
| 2017 | 48.0% | ₩47.24 Billion | ₩98.37 Billion | ₩51.12 Billion | ▼ -28.1 pp |
| 2016 | 76.2% | ₩147.69 Billion | ₩193.89 Billion | ₩46.21 Billion | — |